Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Sep 30, 2022

Accession no.
0001209191-22-051669
Filed
Sep 30, 2022
Trade date
Aug 16-Sep 27, 2022
Filing delay
45 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.38K. It was filed 45 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2022Common StockPPurchaseAcquired+32$2.35+$75.223,287Direct
Aug 17, 2022Common StockPPurchaseAcquired+32$2.31+$73.9223,319Direct
Aug 18, 2022Common StockPPurchaseAcquired+32$2.23+$71.3623,351Direct
Aug 19, 2022Common StockPPurchaseAcquired+32$2.35+$75.223,383Direct
Aug 22, 2022Common StockPPurchaseAcquired+32$2.51+$80.3223,415Direct
Aug 23, 2022Common StockPPurchaseAcquired+32$2.59+$82.8823,447Direct
Aug 24, 2022Common StockPPurchaseAcquired+32$2.59+$82.8823,479Direct
Aug 25, 2022Common StockPPurchaseAcquired+32$2.62+$83.8423,511Direct
Aug 26, 2022Common StockPPurchaseAcquired+32$2.55+$81.623,543Direct
Aug 29, 2022Common StockPPurchaseAcquired+34$2.44+$82.9623,577Direct
Aug 30, 2022Common StockPPurchaseAcquired+34$2.38+$80.9223,611Direct
Aug 31, 2022Common StockPPurchaseAcquired+34$2.36+$80.2423,645Direct
Sep 1, 2022Common StockPPurchaseAcquired+34$2.39+$81.2623,679Direct
Sep 2, 2022Common StockPPurchaseAcquired+34$2.42+$82.2823,713Direct
Sep 6, 2022Common StockPPurchaseAcquired+34$2.15+$73.123,747Direct
Sep 7, 2022Common StockPPurchaseAcquired+34$2.24+$76.1623,781Direct
Sep 8, 2022Common StockPPurchaseAcquired+34$2.22+$75.4823,815Direct
Sep 9, 2022Common StockPPurchaseAcquired+29$2.21+$64.0923,844Direct
Sep 12, 2022Common StockPPurchaseAcquired+34$2.46+$83.6423,878Direct
Sep 13, 2022Common StockPPurchaseAcquired+34$2.45+$83.323,912Direct
Sep 14, 2022Common StockPPurchaseAcquired+34$2.51+$85.3423,946Direct
Sep 15, 2022Common StockPPurchaseAcquired+34$2.47+$83.9823,980Direct
Sep 16, 2022Common StockPPurchaseAcquired+34$2.49+$84.6624,014Direct
Sep 19, 2022Common StockPPurchaseAcquired+31$2.56+$79.3624,045Direct
Sep 20, 2022Common StockPPurchaseAcquired+31$2.54+$78.7424,076Direct
Sep 21, 2022Common StockPPurchaseAcquired+31$2.59+$80.2924,107Direct
Sep 22, 2022Common StockPPurchaseAcquired+31$2.51+$77.8124,138Direct
Sep 23, 2022Common StockPPurchaseAcquired+31$2.55+$79.0524,169Direct
Sep 26, 2022Common StockPPurchaseAcquired+31$2.49+$77.1924,200Direct
Sep 27, 2022Common StockPPurchaseAcquired+31$2.57+$79.6724,231Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)